Brief: Compass Therapeutics Reports 2026 Third Quarter Financial Results
BRIEF-Compass Therapeutics Reports 2026 Third Quarter Financial Results Nov 9 (Reuters) -
COMPASS THERAPEUTICS Q3 BASIC EPS USD -0.15
COMPASS THERAPEUTICS Q3 NET INCOME USD -27.171 MILLION
COMPASS THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -28.8 MILLION
Source text: ID:nGNX8njxd4
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compass Therapeutics
See all newsBrief: Compass Therapeutics Reports 2026 Third Quarter Financial Results
Compass Therapeutics Q3 net loss widens on higher R&D expenses
Brief: Compass Announces Inducement Grants Under Nasdaq Listing Rule
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify